FDAMay 9, 2019drug

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

What to do

FDA enforcement status: Terminated

Brands named

american health packagingamericanamerican health

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →